Latin America healthcare markets

178 reports across 5 categories, with market size and growth to 2033.

Health in Latin America: WHO figures

Latest figure for each country we report on in Latin America (WHO)
MeasureBrazilMexicoEcuador
Diabetes (adults) % of adults 12.9 202214.3 202212.7 2022
Obesity (adults) % of adults 30.1 202437.4 202428.9 2024
High blood pressure (ages 30–79) % of adults 30–79 45.0 201932.1 201927.2 2019
Anaemia in women 15–49 % of women 21.3 202313.2 202320.2 2023
Universal health coverage index index (0–100) 84 202379 202378 2023
Road traffic deaths per 100,000 people 15.4 202311.2 202319.8 2023
Healthy life expectancy years 63.8 202363.1 202366.5 2023
Early deaths from long-term diseases % 14.6 202315.4 202310.5 2023
Tobacco use (adults) % of adults 11.5 202515.6 202510.0 2025
Not active enough (adults) % of adults 40.4 202228.0 202222.8 2022
Alcohol drunk per person litres of pure alcohol (15+) 10.4 20246.7 20243.2 2024
Fine dust in the air (PM2.5) µg per m³ 20.4 202316.1 20238.1 2023

Latin America: People and health spending

Latest figure for each country we report on in Latin America (World Bank)
MeasureBrazilMexicoEcuador
Population people 212.8 million 2025131.9 million 202518.3 million 2025
Life expectancy at birth years 76.0 202475.3 202477.6 2024
People aged 65 and over % of people 11.5 20258.5 20258.6 2025
Health spending per person US$ per person 1,010 2023761 2023509 2023
Health spending (% of GDP) % of GDP 9.7 20235.5 20237.6 2023
Out-of-pocket spending % of health spending 26.2 202341.2 202330.9 2023
Doctors per 1,000 people 2.36 20232.59 20222.31 2020
Nurses and midwives per 1,000 people 5.50 20233.03 20222.51 2018
Hospital beds per 1,000 people 2.52 20211.01 20221.32 2023

Companies most covered in Latin America

All 178 Latin America markets

Each market name opens its Latin America report. To compare one market across every country, see market statistics.

Digital Health 41 markets
Digital Health markets in Latin America
Market20232033 (projected)CAGR Active trials
3D Laparoscopy Imaging Systems $144 Mn $302 Mn 7.7% 0
3D Printed Implants $162 Mn $627 Mn 14.5% 2
3D Printing in Medical Application $108 Mn $745 Mn 21.3% 3
Artificial Intelligence (AI) in Drugs Discovery $27 Mn $297 Mn 27.1% 12
Artificial Intelligence (AI) in Healthcare – – – 55
Artificial Intelligence (AI) in Life Sciences $99 Mn $1.1 Bn 27.7% 36
Artificial Intelligence (AI) in Medical Imaging $41 Mn $415 Mn 26.2% 10
Artificial Intelligence (AI) in Medicine $374 Mn $9.7 Bn 38.5% 55
Artificial Intelligence (AI) in Pharma – – – 12
Artificial Intelligence (AI) in Radiology $27 Mn $361 Mn 29.6% 5
Artificial Intelligence (AI) in Remote Patient Monitoring $41 Mn $622 Mn 31.4% 2
Artificial Intelligence (AI) Machine Learning(ML) in Healthcare $86 Mn $2.3 Bn 39% 55
Blockchain in Genomics $100 Mn $2.8 Bn 39.3% 0
Blockchain-as-a-Service $95 Mn $1.3 Bn 30.3% 0
Brain Imaging, Biomarkers and NeuroInformatics $31 Mn $53 Mn 5.7% 78
Brain PET-MRI Systems $15 Mn $32 Mn 7.5% 66
Clinical Alarm Management $78 Mn $119 Mn 4.3% 2
Clinical Data Management Systems $113 Mn $379 Mn 12.9% 2
Connected Healthcare Market $2.6 Bn $31.5 Bn 28.1% 30
Decentralized Clinical Trials(DCTs) $74 Mn $320 Mn 15.8% 133
Dental 3D Printing $153 Mn $1.1 Bn 21.5% 2
Dental CAD/CAM $149 Mn $424 Mn 11% 4
Digital Biomarkers $198 Mn $4.4 Bn 36.5% 38
Digital diabetes care $577 Mn $3.7 Bn 20.3% 31
Digital Pathology Systems $54 Mn $213 Mn 14.7% 59
Digital Therapeutics $306 Mn $2.2 Bn 22% 149
Digital Twin $77 Mn $730 Mn 25.3% 2
Digital X-ray $783 Mn $1.5 Bn 6.8% 140
Electronic Health Record $1.6 Bn $2.7 Bn 5.2% 35
Healthcare Information System $13.1 Bn $68.9 Bn 18.1% 273
Healthcare IT $21.7 Bn $76.4 Bn 13.4% 61
Home Healthcare $16.3 Bn $38.2 Bn 8.9% 123
Internet Of Things In Healthcare $4.5 Bn $23.5 Bn 18% 1
IoT in Healthcare $8.1 Bn $42.9 Bn 18.1% 1
Long-term Care Software $158 Mn $564 Mn 13.6% 13
Mental Health Apps $252 Mn $1.8 Bn 21.7% 9
Pathology Imaging Systems $73 Mn $245 Mn 12.9% 59
Point of Care Diagnostics $2 Bn $4.6 Bn 8.4% 653
Remote Medication Management $175 Mn $914 Mn 18% 19
Remote Patient Monitoring $71 Mn $398 Mn 18.8% 27
Werable Healthcare Devices $1.5 Bn $9.7 Bn 20.8% 22
Healthcare Services 24 markets
Healthcare Services markets in Latin America
Market20232033 (projected)CAGR Active trials
Alopecia areata – – – 10
Alzheimers Dignostic $95 Mn $202 Mn 7.9% 24
Ambulance Service $1.4 Bn $3.1 Bn 8.1% 97
Ambulatory Surgery Center $1.8 Bn $3.6 Bn 7.1% 597
Antimicrobial Susceptibility Testing – – – 1
Bioinformatics $549 Mn $2.3 Bn 15.4% 2
Biomaterial Wound Dressing $369 Mn $775 Mn 7.7% 5
Blood Gas and Electrolyte Analyzers $126 Mn $257 Mn 7.4% 29
Bone Cancer Diagnostic $50 Mn $111 Mn 8.4% 30
Brain Cancer Diagnostic $68 Mn $264 Mn 14.6% 33
Breast Cancer Diagnostic $185 Mn $429 Mn 8.8% 177
Clinical Laboratory Service – – – 399
Dental Care Service – – – 19
Dental Imaging $153 Mn $359 Mn 8.9% 19
Dermatology Diagnostic $1.2 Bn $3.7 Bn 12.2% 188
Fertility Service $945 Mn $1.9 Bn 7.1% 5
Healthcare Electronic Data Interchange (EDI) $180 Mn $484 Mn 10.4% 7
Healthcare In Vitro Diagnostic $3.8 Bn $6 Bn 4.8% 6
Hospitals and Health Systems $196 Bn $371.5 Bn 6.6% 2,105
Medical Billing $203 Mn $652 Mn 12.4% 3
Medical Tourism $3.3 Bn $11.5 Bn 13.2% 1
Nursing Education $464 Mn $1.1 Bn 9.1% 9
Patient Support Programs (PSP) $774 Mn $2.7 Bn 16.8% 40
Point Of Care (PoC) Molecular Diagnostic $842 Mn $2.2 Bn 10.3% 138
Medical Devices 27 markets
Medical Devices markets in Latin America
Market20232033 (projected)CAGR Active trials
Acute Care Needleless Connectors $22 Mn $50 Mn 8.5% –
Advanced Bipolar Direct Energy Devices $140 Mn $352 Mn 9.7% –
Aesthetic Lasers and Energy Devices $73 Mn $250 Mn 13.1% –
Air Ambulance Life Support Solutions $201 Mn $527 Mn 10.1% –
Airway Management Devices $90 Mn $164 Mn 6.2% –
Anastomosis Devices $142 Mn $300 Mn 7.8% –
Anesthesia & Respiratory Devices $1.3 Bn $3.5 Bn 10.5% –
Anesthesia Monitoring Devices $119 Mn $422 Mn 13.5% –
Angiography Devices $560 Mn $1.1 Bn 7.3% –
Angioplasty Balloons $183 Mn $292 Mn 4.8% –
Anti-Snoring Devices $56 Mn $143 Mn 9.8% –
Apheresis Equipments $114 Mn $229 Mn 7.2% –
Arrhythmia Monitoring Devices $270 Mn $508 Mn 6.5% –
Assisted Walking Aids $104 Mn $194 Mn 6.5% –
Audiology Devices $352 Mn $720 Mn 7.4% –
Defibrillator $798 Mn $1.6 Bn 6.9% –
Dental Articulators $18 Mn $36 Mn 7.4% –
Dental Caries Detectors $17 Mn $56 Mn 12.8% –
Dental Diagnostic and Surgical Equipments $539 Mn $1.2 Bn 8.1% –
Dental X-Ray Equipments $79 Mn $173 Mn 8.2% –
Diabetes Care Devices $1.9 Bn $3.7 Bn 6.9% 22
Digital Diabetes Management – – – –
Direct Energy Medical Devices $497 Mn $890 Mn 6% –
Disposable Surgical Devices $407 Mn $903 Mn 8.3% –
Insulin Delivery Devices $715 Mn $1.5 Bn 7.5% –
Insulin Patch Pumps $40 Mn $136 Mn 13% –
Rehabilitation Equipments $901 Mn $1.8 Bn 7.1% –
OTC & Nutraceuticals 48 markets
OTC & Nutraceuticals markets in Latin America
Market20232033 (projected)CAGR Active trials
Adaptogens $365 Mn $903 Mn 9.5% –
Amino Acid – – – –
Anthelmintic Drug – – – –
Antioxidants – – – –
Antipyretics OTC – – – –
BCAA Supplement $63 Mn $132 Mn 7.7% –
Beauty Supplements $185 Mn $487 Mn 10.2% –
Biotin Supplement $18 Mn $32 Mn 6% –
Bone & Joint Health Supplements $540 Mn $1.1 Bn 7.4% –
Calcium Supplements $113 Mn $221 Mn 7% –
Cannabidiol (CBD) Supplements $239 Mn $1.2 Bn 17.8% –
Cardiovascular Health Supplements $306 Mn $585 Mn 6.7% –
Clinical Nutrition $1.3 Bn $2.8 Bn 8.1% –
Coenzyme Q10 $23 Mn $58 Mn 10% –
Collagen Supplements $99 Mn $197 Mn 7.1% –
Creatine $27 Mn $55 Mn 7.3% –
Dietary Supplements $13.9 Bn $27.8 Bn 7.2% –
Eye Health Supplements $140 Mn $280 Mn 7.2% –
Functional Food $12.8 Bn $26.9 Bn 7.7% –
Hair Growth Supplements $81 Mn $180 Mn 8.3% –
Herbal Supplements $3.7 Bn $8.4 Bn 8.6% –
Immune Health Supplement – – – –
Iron Supplement $90 Mn $186 Mn 7.5% –
Men's Health Supplements $815 Mn $1.7 Bn 7.8% –
Mood and Stress Supplements $473 Mn $1.1 Bn 9.1% –
Nutritional Supplements $17.3 Bn $36.7 Bn 7.8% –
Omega 3 Fatty Acid $185 Mn $413 Mn 8.4% –
Oncology Nutrition $95 Mn $210 Mn 8.3% –
Osteoporosis Supplements $140 Mn $288 Mn 7.5% –
Over The Counter (OTC) Analgesics $990 Mn $1.5 Bn 4.4% –
Over The Counter (OTC) Antifungal $113 Mn $180 Mn 4.8% –
Over The Counter (OTC) Consumer $6.8 Bn $12.4 Bn 6.2% –
Over The Counter (OTC) Drugs $8 Bn $13.9 Bn 5.7% –
Over The Counter (OTC) Gastrointestinal Drugs $252 Mn $407 Mn 4.9% –
Over The Counter (OTC) Medications for Cough, Cold & Flu Drugs $653 Mn $1.1 Bn 5.1% –
Over The Counter (OTC) Ophthalmic Drugs $162 Mn $277 Mn 5.5% –
Over The Counter (OTC) Pharmaceuticals $8 Bn $13.9 Bn 5.7% –
Over The Counter (OTC) Sleep Aid Products $239 Mn $389 Mn 5% –
Over The Counter (OTC) Vitamins and Minerals $1.4 Bn $2.7 Bn 6.5% –
Plant-Based Supplements $554 Mn $1.3 Bn 9% –
Prebiotics $365 Mn $1.2 Bn 12.8% –
Probiotic Supplements for Gut Health $275 Mn $604 Mn 8.2% –
Protein Supplement $900 Mn $2 Bn 8.4% –
Sports Nutrition $2.3 Bn $5.5 Bn 8.9% –
Vitamin B12(Cobalamin) $14 Mn $25 Mn 6.5% –
Vitamin D Supplements – – – –
Weight Management Supplement – – – –
Women's Health Supplements $900 Mn $1.9 Bn 7.8% –
Pharmaceuticals 38 markets
Pharmaceuticals markets in Latin America
Market20232033 (projected)CAGR Active trials
Abuse Deterrent Opioids – – – –
Alexipharmic Drugs – – – –
Alopecia Drugs (Hair Loss) – – – –
Alzheimer Drugs $225 Mn $478 Mn 7.8% –
Aminoglycosides – – – –
Anemia Drugs – – – –
Anti-Aging $4 Bn $9.5 Bn 9.1% –
Anti-Depressants Drugs $811 Mn $1.2 Bn 3.7% –
Anti-Nerve Growth Factor – – – –
Anti-Venom – – – –
Anticoagulants – – – –
Antithrombotic Drugs – – – –
Artificial Skin $113 Mn $217 Mn 6.8% –
Asthma & COPD Drugs $2.2 Bn $3.6 Bn 5% –
Atherosclerosis Drugs – – – –
Atopic Dermatitis Drugs $505 Mn $1.7 Bn 13.2% –
Autologous Matrix-induced Chondrogenesis – – – –
Axial Spondyloarthritis (axSpA) – – – –
Biological Safety Testing – – – –
Biosimilar Monoclonal Antibodies – – – –
Biosimilars $1.7 Bn $16.6 Bn 25.9% –
Blood Plasma – – – –
Bone Marrow Aspirate Concentrates – – – –
Burn Care – – – –
Burn Ointment – – – –
Cancer Supportive Care Drugs $1.1 Bn $1.9 Bn 5.7% –
Cannabidiol (CBD) $992 Mn $5.1 Bn 17.8% –
Cannabis $1.5 Bn $5.9 Bn 14.5% –
Cell Based Immunotherapy $747 Mn $6.4 Bn 24% –
Contraceptives Drugs $1.1 Bn $2.4 Bn 7.8% –
Cord Blood Banking Service $86 Mn $176 Mn 7.5% –
Diabetes Management $3.5 Bn $7.6 Bn 8.1% –
Diabetic Retinopathy Drugs $486 Mn $956 Mn 7% –
Epilepsy Drugs $432 Mn $671 Mn 4.5% –
Gastroesophageal Reflux Disease (GERD) Drugs $234 Mn $318 Mn 3.1% –
Gastrointestinal Drugs $2.4 Bn $4.2 Bn 5.6% –
HIV Drugs $1.4 Bn $2.6 Bn 6.8% –
Oncology/Cancer Drugs $8 Bn $19.6 Bn 9.4% –

"–" means we have no size for that market here yet. Values for 2033 are projected from the 2023 size and the CAGR.

Sources: market sizes and growth: Acuitas Health Analytics research. Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide, and one trial can count in more than one market. Health figures: WHO Global Health Observatory. People and health spending: World Bank. Public figures fetched 10 Nov 2026.

All 178 Latin America reports Other countries